Value
3.0/10data confidence 33%| Component | Sub-score |
|---|---|
| P/S | 0.0 |
| Analyst target | 5.0 |
- ▸Expensive valuation
AGIO · Why this verdict
Why Agios Pharmaceuticals (AGIO) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.7/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Agios carries deep quality deficiencies — free cash flow at -405% of revenue, no competitive moat, and quality well below the minimum investment threshold — while technically strong momentum and three consecutive earnings beats reflect near-term execution; the risk/reward geometry of 0.67 to 1 and short interest at 12% make this a setup to avoid absent a catalyst that substantially improves the fundamental picture.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Short interest at 12% of float combined with a put/call ratio of 7.14 — far above typical levels — indicates deep institutional skepticism and heavy hedging activity, reflecting concerns about binary event risk concentrated in a narrow product pipeline. Risk breakdown | Short interest falls below 6% and put/call ratio normalizes below 2.0, consistent with positioning that reflects improving market confidence rather than defensive hedging. | ↑Improving |
| CounterShort interest of 12% represents potential forced buying if a positive catalyst materializes — the same concentration of bearish positioning that signals skepticism also creates conditions for a powerful upside move if the product pipeline surprises favorably. | ||
Free cash flow at -405% of revenue, no identifiable competitive moat, and a quality score well below the minimum floor mean the business is consuming cash at a rate that vastly exceeds its revenue — the investment case rests entirely on a narrow product portfolio achieving commercial scale before capital is exhausted. Quality breakdown | FCF conversion improves above -100% of revenue and the Piotroski F-Score rises above 5/9 within four quarters, signaling meaningful progress toward financial sustainability. | →Stable |
| CounterAfter a miss in the oldest reported quarter, three consecutive beats followed including the most recent period; if the product portfolio achieves commercial scale, cash burn could improve rapidly from a low base and the quality picture could change quickly. | ||
Price momentum is the one clearly positive signal — the stock has built above its 200-day moving average with a bullish MACD and rising on-balance volume, delivering technical strength that has driven the shares meaningfully despite poor underlying fundamentals. Momentum breakdown | Momentum sustains above the 5.5 threshold for the next three months, keeping the price above the 200-day moving average as the market continues to reward execution progress. | ↓Deteriorating |
| CounterA death cross warning was recently flagged before momentum recovered; technical strength built on weak fundamentals is fragile — a single pipeline disappointment or earnings miss could break the uptrend and remove the only bullish signal in the setup. | ||
With upside to the analyst consensus of 10.1% against downside of 15%, the reward-to-risk ratio of 0.67 to 1 falls well short of the 1.5-to-1 minimum for an acceptable setup — the geometric case for a new position does not hold at current prices. Engine gate (failed) | Upside to the analyst consensus target expands above 20% — either through a price pullback or material analyst target upgrades — restoring a favorable risk/reward ratio before any new capital is committed. | →Stable |
| CounterA favorable risk/reward in this situation requires the stock to fall significantly or analysts to raise targets substantially; if a pipeline catalyst drives a rapid re-rating, the geometry can flip quickly and today's unfavorable setup becomes an entry point missed. | ||
Short interest at 12% of float combined with a put/call ratio of 7.14 — far above typical levels — indicates deep institutional skepticism and heavy hedging activity, reflecting concerns about binary event risk concentrated in a narrow product pipeline.
↑ImprovingRisk breakdown
- Expectation
- Short interest falls below 6% and put/call ratio normalizes below 2.0, consistent with positioning that reflects improving market confidence rather than defensive hedging.
CounterShort interest of 12% represents potential forced buying if a positive catalyst materializes — the same concentration of bearish positioning that signals skepticism also creates conditions for a powerful upside move if the product pipeline surprises favorably.
Free cash flow at -405% of revenue, no identifiable competitive moat, and a quality score well below the minimum floor mean the business is consuming cash at a rate that vastly exceeds its revenue — the investment case rests entirely on a narrow product portfolio achieving commercial scale before capital is exhausted.
→StableQuality breakdown
- Expectation
- FCF conversion improves above -100% of revenue and the Piotroski F-Score rises above 5/9 within four quarters, signaling meaningful progress toward financial sustainability.
CounterAfter a miss in the oldest reported quarter, three consecutive beats followed including the most recent period; if the product portfolio achieves commercial scale, cash burn could improve rapidly from a low base and the quality picture could change quickly.
Price momentum is the one clearly positive signal — the stock has built above its 200-day moving average with a bullish MACD and rising on-balance volume, delivering technical strength that has driven the shares meaningfully despite poor underlying fundamentals.
↓DeterioratingMomentum breakdown
- Expectation
- Momentum sustains above the 5.5 threshold for the next three months, keeping the price above the 200-day moving average as the market continues to reward execution progress.
CounterA death cross warning was recently flagged before momentum recovered; technical strength built on weak fundamentals is fragile — a single pipeline disappointment or earnings miss could break the uptrend and remove the only bullish signal in the setup.
With upside to the analyst consensus of 10.1% against downside of 15%, the reward-to-risk ratio of 0.67 to 1 falls well short of the 1.5-to-1 minimum for an acceptable setup — the geometric case for a new position does not hold at current prices.
→StableEngine gate (failed)
- Expectation
- Upside to the analyst consensus target expands above 20% — either through a price pullback or material analyst target upgrades — restoring a favorable risk/reward ratio before any new capital is committed.
CounterA favorable risk/reward in this situation requires the stock to fall significantly or analysts to raise targets substantially; if a pipeline catalyst drives a rapid re-rating, the geometry can flip quickly and today's unfavorable setup becomes an entry point missed.
Per-dimension breakdown
Quality
2.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Net margin | 0.0 |
| Current ratio | 5.0 |
| FCF quality | 0.0 |
| Moat | 5.8 |
| Piotroski F | 4.4 |
- ▸Cash-burning: FCF -279% of revenue
- ▸Quality concerns
Growth
5.0/10data confidence 50%Momentum
6.6/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.2 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 0.0 |
- ▸Overbought (RSI 76)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 6.0 |
| Analyst rating | 6.8 |
| Price target | 7.6 |
- ▸Light analyst coverage (8.0) — signal dampened
Insider
5.5/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 8.4 |
| notable moves | 7.0 |
- ▸Modest insider selling — $989,042 (0.043% of mkt cap)
- ▸Institutions accumulating
Peer rank
5.7/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 2.5 |
| quality rank | 4.7 |
| growth rank | 9.3 |
- ▸Industry growth leader
Technical
2.8/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.3 |
| support resistance | 0.3 |
| 52w position | 6.7 |
Risk (lower is worse)
5.3/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 4.2 |
| days to cover | 4.6 |
| volatility | 2.1 |
| put call | 6.7 |
| implied vol | 0.0 |
| beta | 9.2 |
| debt equity | 9.9 |
| news risk | 6.0 |
- ▸High IV: 96%
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
5.4/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 4.4 |
| news activity | 6.0 |
- ▸Strong earnings: 3B/1M
- ▸Earnings in 6 days
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCK:QUALITY_FLOORPassed (6)
- MOMENTUM:6.6>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_BOOST:ANALYST:0.50
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
- ASYMMETRY:0.3<1.5@spot
- EARNINGS_PROXIMITY:6d<=7d
Warning (0)
none
Reward-to-Risk
0.26
Upside
+3.9%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The SELL_IF_HOLDING verdict reflects the ASYMMETRY gate's 0.3<1.5@spot outcome against Sentiment at 6.8 and asymmetric R:R of 0.26.
The strongest dimensions are Sentiment at 6.8, Momentum at 6.6, and Peer rank at 5.7; the weakest are Quality at 2.2, Technical at 2.8, and Value at 3.0. The V9 engine flagged 2 failed gates, producing an asymmetric reward-to-risk of 0.26 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Deep Quality Deficiency Cash Burn
Trip ifFCF conversion improves above -50% of revenue for 2 consecutive quarters, indicating meaningful progress toward cash sustainability.
- P2Strong Near Term Momentum
Trip ifMomentum score falls below 5.5 for 2 consecutive months, removing the only bullish signal.
- P3Elevated Institutional Skepticism
Trip ifShort interest falls below 6% of float for 2 consecutive months, signaling bearish positioning has unwound.
- P4Unfavorable Risk Reward Geometry
Trip ifUpside to take-profit target exceeds 20% as analyst targets are materially raised or price pulls back.